Literature DB >> 16618795

Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.

P N Palma1, M L Rodrigues, M Archer, M J Bonifácio, A I Loureiro, D A Learmonth, M A Carrondo, P Soares-da-Silva.   

Abstract

In this work, we present a comparative case study of "ortho-" and "meta-nitrated" catecholic inhibitors of catechol-O-methyltransferase (COMT), with regard to their interaction with the catalytic site of the enzyme and the in vitro regioselective formation of their mono-O-methyl ether metabolites. In particular, the effects of altering the attachment position of the inhibitors' side-chain substituent, within the classic nitrocatechol pharmacophore, were investigated. For this purpose, we compared two simple regioisomeric nitrocatechol-type inhibitors of COMT, BIA 3-228 and BIA 8-176, which contain the benzoyl substituent attached at the meta and ortho positions, respectively, relative to the nitro group. The two compounds were slowly O-methylated by COMT in vitro, but the particular substitution pattern of each compound was shown to have a profound impact on the regioselectivity of their O-methylation. To provide a plausible interpretation of these results, a comprehensive analysis of the protein-inhibitor interactions and of the relative chemical susceptibility to O-methylation of the catechol hydroxyl groups was performed by means of docking simulations and ab initio molecular orbital calculations. The major structural and chemical factors that determine the enzyme regioselectivity of O-methylation were identified, and the X-ray structure of the complex of COMT with S-adenosyl-l-methionine and BIA 8-176 is herein disclosed. This is the first reported structure of the soluble form of COMT complexed with a nitrocatecholic inhibitor having a bulky substituent group in adjacent position (ortho) to the nitro group. Structural and dynamic aspects of this complex are analyzed and discussed, in the context of the present study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618795     DOI: 10.1124/mol.106.023119

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  15 in total

1.  Tau-derived-hexapeptide 306VQIVYK311 aggregation inhibitors: nitrocatechol moiety as a pharmacophore in drug design.

Authors:  Tarek Mohamed; Tuan Hoang; Masoud Jelokhani-Niaraki; Praveen P N Rao
Journal:  ACS Chem Neurosci       Date:  2013-09-19       Impact factor: 4.418

2.  Structural characterization of the mitomycin 7-O-methyltransferase.

Authors:  Shanteri Singh; Aram Chang; Randal D Goff; Craig A Bingman; Sabine Grüschow; David H Sherman; George N Phillips; Jon S Thorson
Journal:  Proteins       Date:  2011-05-02

3.  Biosynthesis of mycobacterial methylmannose polysaccharides requires a unique 1-O-methyltransferase specific for 3-O-methylated mannosides.

Authors:  Jorge Ripoll-Rozada; Mafalda Costa; José A Manso; Ana Maranha; Vanessa Miranda; André Sequeira; M Rita Ventura; Sandra Macedo-Ribeiro; Pedro José Barbosa Pereira; Nuno Empadinhas
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-03       Impact factor: 11.205

4.  Ground- and excited-state stability of the conformers of 3,5-dinitrocatechol and its complexes with W(VI) and V(V): combined theoretical and experimental study.

Authors:  V B Delchev; K B Gavazov; I G Shterev
Journal:  J Mol Model       Date:  2014-12-10       Impact factor: 1.810

Review 5.  Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders.

Authors:  Zhiguo Ma; Hongming Liu; Baojian Wu
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

6.  The crystal structure of the novobiocin biosynthetic enzyme NovP: the first representative structure for the TylF O-methyltransferase superfamily.

Authors:  Inmaculada Gómez García; Clare E M Stevenson; Isabel Usón; Caren L Freel Meyers; Christopher T Walsh; David M Lawson
Journal:  J Mol Biol       Date:  2009-10-24       Impact factor: 5.469

7.  Structure and mechanism of the rebeccamycin sugar 4'-O-methyltransferase RebM.

Authors:  Shanteri Singh; Jason G McCoy; Changsheng Zhang; Craig A Bingman; George N Phillips; Jon S Thorson
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

8.  Mapping the conformational space accessible to catechol-O-methyltransferase.

Authors:  Andreas Ehler; Jörg Benz; Daniel Schlatter; Markus G Rudolph
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-07-25

9.  Effects of Active-Site Modification and Quaternary Structure on the Regioselectivity of Catechol-O-Methyltransferase.

Authors:  Brian J C Law; Matthew R Bennett; Mark L Thompson; Colin Levy; Sarah A Shepherd; David Leys; Jason Micklefield
Journal:  Angew Chem Int Ed Engl       Date:  2016-01-21       Impact factor: 15.336

10.  Computational Investigation of the Interplay of Substrate Positioning and Reactivity in Catechol O-Methyltransferase.

Authors:  Niladri Patra; Efthymios I Ioannidis; Heather J Kulik
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.